TARUGI, Patrizia Maria
 Distribuzione geografica
Continente #
NA - Nord America 16.332
AS - Asia 7.650
EU - Europa 7.114
SA - Sud America 1.016
AF - Africa 145
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 18
Totale 32.301
Nazione #
US - Stati Uniti d'America 16.116
SG - Singapore 2.486
GB - Regno Unito 2.445
CN - Cina 2.039
IT - Italia 1.550
HK - Hong Kong 999
BR - Brasile 782
VN - Vietnam 779
SE - Svezia 730
DE - Germania 535
FI - Finlandia 395
UA - Ucraina 337
RU - Federazione Russa 310
FR - Francia 279
KR - Corea 222
TR - Turchia 194
IN - India 191
BD - Bangladesh 167
BG - Bulgaria 146
ID - Indonesia 117
NL - Olanda 94
CA - Canada 83
MX - Messico 77
AR - Argentina 73
IQ - Iraq 64
JP - Giappone 59
PK - Pakistan 56
BE - Belgio 50
AE - Emirati Arabi Uniti 42
ES - Italia 39
ZA - Sudafrica 34
CO - Colombia 32
EC - Ecuador 31
IE - Irlanda 31
PL - Polonia 25
AT - Austria 24
AU - Australia 24
CL - Cile 24
UZ - Uzbekistan 23
VE - Venezuela 23
KE - Kenya 21
CH - Svizzera 19
MY - Malesia 19
SA - Arabia Saudita 19
PH - Filippine 18
DZ - Algeria 17
EG - Egitto 17
CZ - Repubblica Ceca 16
TN - Tunisia 16
TW - Taiwan 16
EU - Europa 15
KZ - Kazakistan 15
NP - Nepal 15
PE - Perù 15
IR - Iran 14
LT - Lituania 14
BZ - Belize 13
MA - Marocco 13
PY - Paraguay 13
UY - Uruguay 12
CR - Costa Rica 11
JO - Giordania 11
PT - Portogallo 11
ET - Etiopia 10
HU - Ungheria 10
IL - Israele 10
AZ - Azerbaigian 9
BA - Bosnia-Erzegovina 9
BO - Bolivia 9
AL - Albania 8
DO - Repubblica Dominicana 8
TH - Thailandia 8
BH - Bahrain 7
OM - Oman 7
LK - Sri Lanka 6
PS - Palestinian Territory 6
DK - Danimarca 5
GE - Georgia 5
GR - Grecia 5
JM - Giamaica 5
KG - Kirghizistan 5
KW - Kuwait 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
PR - Porto Rico 4
QA - Qatar 4
RO - Romania 4
EE - Estonia 3
GT - Guatemala 3
KH - Cambogia 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
MM - Myanmar 2
NE - Niger 2
Totale 32.267
Città #
Southend 1.766
Fairfield 1.667
Singapore 1.614
Ashburn 1.589
Santa Clara 1.499
Woodbridge 1.149
Hong Kong 976
Houston 893
Jacksonville 702
Hefei 700
San Jose 681
Chandler 664
Seattle 638
Wilmington 615
Ann Arbor 522
Cambridge 489
Dearborn 403
Nyköping 396
Beijing 355
London 351
Helsinki 282
Los Angeles 252
Modena 252
Ho Chi Minh City 242
Seoul 209
The Dalles 209
Chicago 202
Council Bluffs 190
Milan 181
Hanoi 174
New York 168
San Diego 151
Princeton 149
Sofia 139
Eugene 110
Buffalo 109
Lauterbourg 107
Rome 101
Moscow 96
Salt Lake City 89
Dallas 84
Shanghai 82
Columbus 81
Jakarta 81
Izmir 74
Des Moines 68
São Paulo 64
Falls Church 61
Grafing 51
Da Nang 46
Elk Grove Village 45
Orem 45
Munich 43
Bremen 39
Frankfurt am Main 39
Naples 39
Rio de Janeiro 37
Tokyo 35
Boardman 34
Brussels 34
Mexico City 32
Atlanta 31
Tampa 30
Nanjing 29
Redwood City 29
Dublin 28
Bologna 25
Brooklyn 25
Detroit 24
Haiphong 24
Toronto 24
Baghdad 23
Chennai 23
Guangzhou 23
Kunming 23
Phoenix 23
Miano 22
Nuremberg 22
Norwalk 21
Tashkent 21
Belo Horizonte 20
Turin 20
San Mateo 19
Kent 18
Padova 18
Paris 18
San Francisco 18
Verona 18
Biên Hòa 17
Florence 17
Kilburn 17
Lahore 17
Montreal 17
Warsaw 16
Wuhan 16
Buenos Aires 15
Manchester 15
Poplar 15
Redondo Beach 15
Reggio Emilia 15
Totale 23.006
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.162
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 528
Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivoproduction and functional evaluation as a potential therapeutic tool forlowering plasma LDL cholesterol. 478
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 459
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol 400
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 370
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia 365
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 365
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 352
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 349
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 344
Altered mRNA splicing in lipoprotein disorders 342
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 338
ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum(PXE). 337
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 336
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 329
The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations 326
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 325
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 316
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 314
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 313
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 312
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 309
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 305
Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia 302
Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins. 302
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 300
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 294
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature 294
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 288
Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B 288
Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis 283
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 282
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 280
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 278
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 277
Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects 277
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 274
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 273
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 272
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 268
Pediatric gallstone disease in familial hypobetalipoproteinemia 268
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia. 268
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 266
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 264
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 264
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 262
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 260
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 259
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia. 258
A 54-year-old diabetic man with low serum cholesterol. 255
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 253
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 253
Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia 252
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 251
Plasma non-cholesterol sterols in primary hypobetalipoproteinemia. 251
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 247
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 246
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 246
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 245
PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia 242
A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia. 241
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 240
β-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia 239
Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia. 238
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 235
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 234
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 234
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux 232
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 231
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations 231
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 228
The protective effect on Cu2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glycosaminoglycan structure 225
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide 225
Influence of chondroitin sulfate charge density, sulfate group position, and molecular mass on Cu2+-mediated oxidation of human low-density lipoproteins: Effect of normal human plasma-derived chondroitin sulfate 223
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 222
Synthesis and secretion of apolipoprotein A-I by chick skin. 222
Microsomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up. 220
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 217
Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and its use for detecting apo-AI mRNA expression in several chick tissues. 217
Characterization of a mutant form of human apolipoprotein B (Thr26_Tyr27del) associated with familial hypobetalipoproteinemia 217
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 216
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia 216
Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome 213
Cholesterol synthesis in freshly isolated human leukocytes. 212
Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function 212
The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick 211
Exome Sequencing in Suspected Monogenic Dyslipidemias 206
Chemical and morphological changes of rat plasma lipoproteins after a prolonged administration of diets containing olive oil and cholesterol. 204
Phenotypic expression of heterozygous familial hypobetalipoproteinemia in three kindreds with novel mutations of apolipoprotein B gene 204
Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene. 203
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 203
Dyslipidemia in rats with hypothyroidism 202
Abetalipoproteinemia in an infant with severe clinical phenotype and a novel mutation 197
Plasma lipoproteins, tissue cholesterol overload, and skeletal muscle apolipoprotein A-I synthesis in the developing chick. 194
Mutation screening of the Otop1 gene in familial benign positional paroxysmal vertigo 194
Hypercholesterolemia in Childhood: How the Response to Diet could Lead to Diagnosis. Lesson from a Case-Report 193
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 193
Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. 187
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 187
Totale 27.734
Categoria #
all - tutte 125.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021377 0 0 0 0 0 0 0 0 0 0 206 171
2021/20222.572 151 283 219 191 56 213 151 106 282 215 454 251
2022/20232.204 257 218 159 179 252 351 40 196 294 46 131 81
2023/20241.654 73 83 149 147 301 148 131 187 74 120 49 192
2024/20255.494 184 50 118 376 1.049 849 444 333 501 241 612 737
2025/20269.956 726 466 932 1.027 1.527 741 1.346 553 951 1.019 668 0
Totale 32.487